New Partnership Expands Scope’s Dry Eye Portfolio

OPTASE HYLO Night Pack shot

Today Scope Eyecare, a leading dry eye company announced a new partnership to further enhance and expand Scope’s OSD/dry eye offering. Known in Europe as VitApos®, OPTASE® HYLO Night® is a preservative-free eye ointment for nighttime use set to launch in June this year followed by more exciting OPTASE® HYLO® products later this year.

Scope Eyecare and Ursapharm Arzneimittel GmbH have been partners collaborating in the European dry eye sector for nearly 12 years. An exciting new partnership for the US paves the way for the next phase of this partnership with the creation and launch of a co-branded range of new and innovative products for the US dry eye market.

The OPTASE® HYLO® cobrand partnership has seen the companies’ R&D teams develop formulations tailored to meet the needs of the US dry eye sufferer across a spectrum of symptom severity. Globally dry eye disease has become increasingly prevalent with an aging population and more recently the huge increase in digital devices driving growth in the sector. Eye doctors and their patients rely on innovative new products to alleviate and manage a range of symptoms associated with the disease.

Scope Eyecare is an innovative 12-year-old healthcare company and market leader in the dry eye market in the UK and Ireland. In 2019 Scope launched its preservative-free OPTASE® Heat, Cleanse & Hydrate (HCH) range in the U.S. and established its U.S. headquarters in New York. Scope now has an extensive, experienced U.S. sales and marketing team to serve its growing customer base of ophthalmologists and optometrists across the U.S.

Scope CEO Tom Freyne said: “We are delighted to enhance and broaden our ocular surface disease range with the OPTASE® HYLO® brand collaboration. Ursapharm and Scope have worked together for a long time and our results in the UK and Ireland have been the consequence of the right partnership and the right response to our products and services from dry eye patients. To now take this tried and tested partnership to the US is an incredibly exciting next chapter in our relationship. These products have been missing in the US market and now we want to work with eye doctors and patients to offer them locally.”

Ursapharm Arzneimittel GmbH is a leading family-run German manufacturer of drugs and medical products for ophthalmology. Its preservative-free, high-quality HYLO Eye Care is European wide the leading dry eye brand. Ursapharm CEO Dominik Holzer commented: “The market entry into the US market is the logical continuation of our international expansion strategy. We are looking forward to taking this important strategic step together with our proven partner Scope.”

“The symptom severity of patients with dry eye disease varies over the course of a day with substantial differences in the characteristics and properties in the tear film,” said Dr. Paul Karpecki, Director, Cornea & External Disease, Kentucky Eye Institute. “Dry eye nighttime ointments have been around for years, but Optase HYLO Night–formerly known as VitA-POS in Europe—is an ointment with a difference and we’re pleased is now available locally in the U.S. through Scope. I’ve used this smooth, highly tolerable ointment for years and it contains Vitamin A*,an excellent choice for a range of ocular surface conditions. These Patients have reported symptomatic relief with this product and I am also seeing improvements in conjunctival staining on assessment.”

OPTASE® HYLO® Night Product Highlights:

  • A preservative free dry eye ointment using white petrolatum, mineral oil, light liquid paraffin and Vitamin A*
  • Over 300 applications per 5g tube
  • For moderate to severe dry eye sufferers

*Inactive ingredient

More details to come soon on the other products in Optase® HYLO® range.

Optase HYLO Night, the dry eye ointment with a difference. Provide patients with a preservative free solution that stays sterile for 6 months, 300 applications and 6 hours comfort and relief.

ABOUT SCOPE: Scope Eyecare is a family run healthcare company dedicated to providing healthcare professionals and consumers with high quality, effective and innovative products. Founded in 2009, Scope offers a range of eyecare products for the treatment of various eyecare conditions including Dry Eye Disease, Blepharitis and MGD.

ABOUT Ursapharm: URSAPHARM GmbH, is a leading family run German manufacturer of drugs and medical products for ophthalmology and was established in 1974. Based in Saarbrucken, and led by Frank and Dominik Holzer, has a presence in over 74 countries with and operates 9 subsidiaries in Europe, Russia, and India. Ursapharm have a major focus on R&D and employ over 700 employees across various functions.